PubMed Health⌕ Search

Biomedical subjects

H Slettebø

Publications and source records attributed to H Slettebø.

7 recordsLinked to original sources
PubMed1998

[Vascular compression and cranial nerve diseases].

This paper offers a review of cranial nerve rhizopathies caused by vascular compression of cranial nerves in the posterior cranial fossa. We present our results of microvascular decompression for trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia caused by compression of the 5th, 7th and 9th cranial nerves, respectively. After a median observation time of 38 months, 20 of 25 patients with trigeminal neuralgia were completely free of pain, and one patient reported more than 50% pain relief. Four out of five patients treated for hemifacial spasms were completely free of spasms. Of two patients treated for glossopharyngeal neuralgia, one reported complete pain relief, whereas the other reported less than 50% pain relief. No serious complications occurred. The results of microvascular decompression reported in the literature reviewed, including results of the treatment of tinnitus and positional vertigo due to compression of the 8th cranial nerve, hypertension due to compression of the 10th cranial nerve and spastic torticollis due to compression of the 11th cranial nerve. It is concluded that the rationale behind microvascular decompression is supported by an extensive amount of data.

Adult↗
PubMed1997

A prospective study of microvascular decompression for trigeminal neuralgia.

In a prospective study of 25 patients with trigeminal neuralgia (TN), we examined the results of microvascular decompression (MVD). Initial pain relief was complete in 22 patients and partial in one. There were two primary failures. After a median observation time of 38 months, 20 of the 22 patients still were completely free of pain, and one patient reported then 50% pain relief. A vascular compression of the trigeminal root was found intra-operatively in 23 patients. No serious complications occurred. Minor but bother-some dyaesthesias were reported by two patients (8%). The results were satisfactory when compared to other MVD studies.

Adult↗
PubMed1993

Long-term results after percutaneous retrogasserian glycerol rhizotomy in patients with trigeminal neuralgia.

We have evaluated the long-term results of percutaneous retrogasserian glycerol rhizotomy (PRGR) in 60 patients with classical trigeminal neuralgia. Complete initial pain relief was achieved in 93% of the patients. Numbness was initially reported by 3/4 of the patients and at follow-up by 1/3, while long-lasting dysaesthesias were an important side effect in 38% of previously untreated patients. The half-life of the method was 47 months in our material, and this figure compares favourably with other previously reported series. The method carries a significant risk of long-lasting and troublesome sensory disturbances. Another disadvantage of the method, reported in the present long-term study, was the high incidence of recurrent neuralgia. We are unable to identify predictors of recurrent neuralgia after PRGR, although major recurrences were more common in patients with unchanged facial sensation postoperatively. In conclusion, PRGR offers safe and reliable relief of pain in patients with trigeminal neuralgia. In spite of the high incidence of recurrence and of long-lasting dysaesthesias it is, in our opinion, the method of choice in the elderly, and particularly suitable for patients at high risk.

Adult↗
PubMed1992

[Kasabach-Merritt syndrome. A differential diagnosis in thrombocytopenia].

The Kasabach-Merritt syndrome consists of hemangioma in association with thrombocytopenia and localized consumption coagulopathy. It is primarily a disease of childhood, but may be seen in adult patients too. When untreated, it involves considerable risk of mortality. Two adult patients are described. The disease can be cured by surgery. We discuss different options for treatment when surgery is not feasible.

Diagnosis, Differential↗
PubMed1992

High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression.

Twenty-eight consecutive patients were given high-dose dexamethasone (96 mg i.v. loading dose, decreasing doses to zero in 14 days) and radiotherapy for epidural spinal cord compression due to malignant disease. There were eight events classified as side effects of the dexamethasone treatment. Four of these were considered as serious (one fatal ulcer with haemorrhage, one rectal bleeding and one gastrointestinal perforation from undetermined origins, and one perforation of the sigmoid colon) giving a total rate of serious side effects of 14.3 percent. Due to the high incidence of serious side effects of the high dexamethasone dose, the regimen was abandoned in favor of a standard dexamethasone dose of 16 mg daily reduced to zero in 14 days. There were three events classified as side effects, but none were considered as serious in 38 consecutive patients receiving this dose. The differences both in total number of side effects and number of serious side effects are statistically significant. There was no significant difference in the number of ambulant patients in the group that received the high dexamethasone dose. We conclude that the high dexamethasone dose in our experience gives an unacceptably high incidence of serious side effects and we have therefore abandoned the regimen in favour of a more standard dexamethasone dose.

Aged↗
PubMed1991

[Treatment of spinal cord compression caused by malignant disease].

Patients suffering from metastatic spinal cord compression can be treated with decompressive surgery and/or radiotherapy. The best treatment regimen remains to be established. In the present paper we report our experience of a therapeutic regimen with main emphasis on radiotherapy, but where selected patients were treated with laminectomy followed by radiotherapy. 67 patients were treated during a two year period, 60 with radiotherapy as the sole treatment modality. The ambulation rate after treatment was 56.7%. Degree of loss of neurological function before treatment and tumour histology were prognostic factors for a successful outcome, defined as the patient's ability to walk after treatment. We emphasize the importance of starting treatment before development of advanced neurological deficits.

Adolescent↗